BridgeMD
New treatment option for Time
Official title Perioperative Analgesic Effect of Different Volumes of Modified Thoracoabdominal Perichondrial Approach on Patients Undergoing Sleeve Gastrectomy: Prospective Randomized Trial
ClinicalTrials.gov ID: NCT07510347
What this study is testing
- What it's testing
- Sleeve gastrectomy is a leading technique in metabolic \& bariatric surgery. It gained ever-increasing popularity among laparoscopic bariatric surgeries and has proved to be a successful method in achieving considerable weight loss in a short time .
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Patients will be eligible for the study if they meet the following criteria:
- Adults aged \> 20 years to 60 years.
- Scheduled for elective laparoscopic sleeve gastrectomy.
You likely can't join if
- Patients will be excluded from the study if any of the following conditions apply:
- American Society of Anesthesiology (ASA) ASA \> class 2.
- History of chronic pain or opioid use for more than 3 months before surgery.
- Previous major abdominal surgery (which may affect M-TAPA how well it works).
- Known hypersensitivity or allergy to local anesthetics (e.g., bupivacaine).
- Coagulopathy or ongoing anticoagulant therapy that could increase bleeding risk.
See the full eligibility criteria
- Patients will be eligible for the study if they meet the following criteria:
- Adults aged \> 20 years to 60 years.
- Scheduled for elective laparoscopic sleeve gastrectomy.
- Patients will be excluded from the study if any of the following conditions apply:
- American Society of Anesthesiology (ASA) ASA \> class 2.
- History of chronic pain or opioid use for more than 3 months before surgery.
- Previous major abdominal surgery (which may affect M-TAPA how well it works).
- Known hypersensitivity or allergy to local anesthetics (e.g., bupivacaine).
- Coagulopathy or ongoing anticoagulant therapy that could increase bleeding risk.
- Local infection at the injection site.
- Neuromuscular disorders affecting pain perception.
- Patient with mental or psychiatric disorders.
The study team makes the final eligibility decision.
Where it's taking place
- Shibīn al Kawm, Menofia, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shibīn al Kawm, Menofia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.